Matrix metalloproteinase-13 expression in the progression of colorectal adenoma to carcinoma: Matrix metalloproteinase-13 expression in the colorectal adenoma and carcinoma

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5653-5658

  Foda, Abd Al Rahman Mohammad ^a   El Hawary, Amira K ^a   Abdel Aziz, Azza ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Adenoma carcinoma sequence; Matrix metalloproteinase 13

Indexed keywords

BIOLOGICAL MARKER; COLLAGENASE 3;

ADULT; AGED; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CYTOPLASM; EARLY CANCER; FAMILIAL COLON POLYPOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MIDDLE AGED;

EID: 84904754070     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1748-9     Document Type: Article

References (25)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-43. (Pubitemid 33586866)
2. GhafoorA, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52:326-41. (Pubitemid 35446605)
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin. 2005;55:74-108.
4. El-Bolkainy TN, Sakr MA, Nouh AA, et al. A comparative study of rectal and colonic carcinoma: demographic, pathologic and TNM staging analysis. J Egypt Nat Cancer Inst. 2006;18:258-63.
5. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma - carcinoma sequence in large bowel. Lancet. 1978;1:245-7. (Pubitemid 8268162)
6. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004;16:558-64. (Pubitemid 39201241)
7. Castaneda FE, Walia B, Vijay-Kumar M, et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology. 2005;129:1991-2008. (Pubitemid 41772976)
8. Kirimlioglu H, Kirimlioglu V, Yilmaz S, et al. Role of matrix metalloproteinase-7 in colorectal adenomas. Dig Dis Sci. 2006;51(11):2068-72. (Pubitemid 44832593)
9. Clapper ML, Hensley HH, Chang WC, et al. Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity. Neoplasia. 2011;13:685-91.
10. Newell KJ, Witty JP, Rodgers WH, et al. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog. 1994;10:199-206. (Pubitemid 24283035)
11. Wilson CL, KJ Hn, PA Ls, et al. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A. 1997;94:1402-7.
12. Cowell S, Knäuper V, Stewart ML, et al. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J. 1998;331:453-8. (Pubitemid 28182159)
13. Mori D, Nakafusa Y, Miyazaki K, et al. Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays. Pathol Res Pract. 2005;201(12):777-89. (Pubitemid 43071565)
14. Foda AA, El-Hawary AK, Abdel-Aziz A. Differential expression of MMP-13 in mucinous and nonmucinous colorectal carcinomas. Ann Diagn Pathol. 2013;17:347-51.
15. Hamilton SR, Bosman FT, Boffetta P, et al. Tumours of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al., editors.WHO classification of tumours of the digestive system. 4th ed. Lyon: IARCPress; 2010. p. 132-82.
16. Shebl AM, Zalata KR, Amin MM, et al. An inexpensive method of small paraffin tissue microarrays using mechanical pencil tips. Diagn Pathol. 2011;6:117.
17. Foda AA. No-cost manual method for preparation of tissue microarrays having high quality comparable to semiautomated methods. Appl Immunohistochem Mol Morphol. 2013;21:271-4.
18. Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol. 2002;55:758-62. (Pubitemid 35231907)
19. Yang B, Gao J, Rao Z, et al. Clinicopathological significance and prognostic value ofMMP-13 expression in colorectal cancer. Scand J Clin Lab Investig. 2012;72:501-5.
20. Tomita T, Iwata K.Matrix metalloproteinases and tissue inhibitors of metalloproteinasas in colonic adenomas-adenocarcinomas. Dis Colon Rectum. 1996;39:1255-64. (Pubitemid 26389536)
21. Heslin MJ, Yan J, Johnson MR, et al. Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg. 2001;233(6):786-92. (Pubitemid 32494559)
22. Rath T, Roderfeld M, Graf J, et al. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential? Inflamm Bowel Dis. 2006;12:1025-35. (Pubitemid 44665472)
23. Gimeno-Garcia AZ, Santana-Rodriguez A, Jimenez A, et al. Upregulation of gelatinases in the colorectal adenoma-carcinoma sequence. Eur J Cancer. 2006;42:3246-52. (Pubitemid 44854506)
24. Lee SW, Ahn YY, Kim YS, et al. The immunohistochemical expression of STAT3, Bcl-xL, and MMP-2 proteins in colon adenoma and adenocarcinoma. Gut and Liver. 2012;6(1):45-51.
25. Takeuchi N, Ichikawa Y, Ishikawa T, et al. Matrilysin gene expression in sporadic and familial colorectal adenomas. Mol Carcinog. 1997;19:225-9. (Pubitemid 27392000)